BRI News

Learn about BRI's world-renowned advancements in autoimmune disease research.

News American Association of Immunologists AAI

Press Release

Seattle, WA - Jan 18, 2024

Benaroya Research Institute President Jane Buckner, MD, Receives 2024 American Association of Immunologists’ Steinman Award for Human Immunology Research

Press Release

Seattle, WA - Jan 5, 2024

Protein LITAF Provides Resistance to Pore-Forming Toxin-Induced Cell Death

External News

December 26, 2023

Science in Seattle: A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab

Read the publication ➡

News Image - Puget Sound Business Journal

Press Release

Seattle, WA - Oct 25, 2023

Benaroya Research Institute’s Dr. Carla Greenbaum Receives Puget Sound Business Journal Lifetime Achievement Award

News

October 9, 2023

BRI Investigator Alice Long, PhD, Interviewed on the Immunology Podcast

Press Release

Seattle, WA - Oct 3, 2023

Benaroya Research Institute Immunologist John Ray Receives 2023 NIH Director’s New Innovator Award

Blog Main Image - Down Syndrome (DS) Girl Under Mother Arm

Press Release

Seattle, WA - Oct 2, 2023

Benaroya Research Institute Receives $9 Million in Funding, With a Focus on Down Syndrome Research

News

September 25, 2023

BRI Investigators Jane Buckner, MD, and Carmen Mikacenic, MD, Interviewed on the Arthritis Life Podcast

External News

September 20, 2023

Researchers zoom in on new ways to view biomolecules in pathogens

Benaroya Research Institute Awarded $3.1 Million National Institutes of Health Grant to Study the Inflammatory Cycle of Common Skin Diseases

News

August 23, 2023

Vlad V. Simianu, MD, MPH, Appointed as Medical Director of Benaroya Research Institute’s Clinical Research Program

News Main Image - Seattle Children's Hospital

External News

July 28, 2023

Invent@SC’s Future Biotech Leaders, a post-doctoral training program developed in partnership with BRI, FHCRC and UW

Former Seahawk Jordan Babineaux talks about the upcoming Boeing Classic, a golf tournament benefiting BRI

Watch the video ➡

External News

July 26, 2023

BRI News

Learn about BRI's world-renowned advancements in autoimmune disease research.

Benaroya Research Institute President Jane Buckner, MD, Receives 2024 American Association of Immunologists’ Steinman Award for Human Immunology Research

Protein LITAF Provides Resistance to Pore-Forming Toxin-Induced Cell Death

Science in Seattle: A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab

Benaroya Research Institute’s Dr. Carla Greenbaum Receives Puget Sound Business Journal Lifetime Achievement Award

BRI Investigator Alice Long, PhD, Interviewed on the Immunology Podcast

Benaroya Research Institute Immunologist John Ray Receives 2023 NIH Director’s New Innovator Award

Benaroya Research Institute Receives $9 Million in Funding, With a Focus on Down Syndrome Research

BRI Investigators Jane Buckner, MD, and Carmen Mikacenic, MD, Interviewed on the Arthritis Life Podcast

Researchers zoom in on new ways to view biomolecules in pathogens

Benaroya Research Institute Awarded $3.1 Million National Institutes of Health Grant to Study the Inflammatory Cycle of Common Skin Diseases

Vlad V. Simianu, MD, MPH, Appointed as Medical Director of Benaroya Research Institute’s Clinical Research Program

Invent@SC’s Future Biotech Leaders, a post-doctoral training program developed in partnership with BRI, FHCRC and UW

Former Seahawk Jordan Babineaux talks about the upcoming Boeing Classic, a golf tournament benefiting BRI

Monitoring T cells may allow prevention of type 1 diabetes

Comment: As Asthma Incidence Rises, Tailor Treatments Better

BRI News

Learn about BRI's world-renowned advancements in autoimmune disease research.

Benaroya Research Institute President Jane Buckner, MD, Receives 2024 American Association of Immunologists’ Steinman Award for Human Immunology Research

Protein LITAF Provides Resistance to Pore-Forming Toxin-Induced Cell Death

Science in Seattle: A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab

Benaroya Research Institute’s Dr. Carla Greenbaum Receives Puget Sound Business Journal Lifetime Achievement Award

BRI Investigator Alice Long, PhD, Interviewed on the Immunology Podcast

Benaroya Research Institute Immunologist John Ray Receives 2023 NIH Director’s New Innovator Award

Benaroya Research Institute Receives $9 Million in Funding, With a Focus on Down Syndrome Research

BRI Investigators Jane Buckner, MD, and Carmen Mikacenic, MD, Interviewed on the Arthritis Life Podcast

Researchers zoom in on new ways to view biomolecules in pathogens

Benaroya Research Institute Awarded $3.1 Million National Institutes of Health Grant to Study the Inflammatory Cycle of Common Skin Diseases

Vlad V. Simianu, MD, MPH, Appointed as Medical Director of Benaroya Research Institute’s Clinical Research Program

Invent@SC’s Future Biotech Leaders, a post-doctoral training program developed in partnership with BRI, FHCRC and UW

Former Seahawk Jordan Babineaux talks about the upcoming Boeing Classic, a golf tournament benefiting BRI

Monitoring T cells may allow prevention of type 1 diabetes

Comment: As Asthma Incidence Rises, Tailor Treatments Better

Pagination